Impact Events
MoreDate | Lead Company | Event | Type | Approval Change | Approval Likelihood |
---|---|---|---|---|---|
1/30/23 | Vera (VERA) | Atacicept for Immunoglobulin A (IgA) Nephropathy (Berger's Disease) | Subscribers Only | Subscribers Only | Subscribers Only |
1/30/23 | Boehringer Ingelheim | SPEVIGO for Psoriasis | Subscribers Only | Subscribers Only | Subscribers Only |
1/27/23 | Johnson & Johnson (JNJ) | Carvykti for Multiple Myeloma (MM) | Subscribers Only | Subscribers Only | Subscribers Only |
1/26/23 | AC Immune (ACIU) | ACI-24 for Alzheimer's Disease (AD) | Subscribers Only | Subscribers Only | Subscribers Only |
1/25/23 | Aridis Pharmaceuticals (ARDS) | Salvecin for Staphylococcal Vaccines and Other Staphylococcus-Specific Agents (Antibacterial) | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
MoreExpected Date Range | Lead Company | Drug | Expected Catalyst |
---|---|---|---|
02/07/23 | Subscribers Only | Subscribers Only | Regulatory - FDA Advisory Panel Brief |
Now - 02/08/23 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
Now - 02/08/23 | Subscribers Only | Subscribers Only | Partnership - Acquisition Completion |
02/08/23 | Subscribers Only | Subscribers Only | Regulatory - PDUFA for sNDA/sBLA |
02/09/23 | Subscribers Only | Subscribers Only | Regulatory - FDA Advisory Panel Meeting |